Company Enlivex Therapeutics Ltd. Deutsche Boerse AG
Equities
1BT
IL0011319527
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 EUR | +0.68% | +12.03% | -35.22% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 15/11/19 |
Dror Mevorach
FOU | Founder | 68 | 31/12/08 |
Director of Finance/CFO | 47 | 31/12/15 | |
Chief Operating Officer | - | - | |
Sigal Arad
HRO | Human Resources Officer | - | - |
Iris Tavor
LAW | General Counsel | - | - |
Einat Galamidi
PRN | Corporate Officer/Principal | - | 21/02/22 |
Oren Elmaliah
AUD | Comptroller/Controller/Auditor | 40 | 31/01/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 25/03/19 |
Avri Havron
BRD | Director/Board Member | 76 | 31/12/13 |
Brian Schwartz
BRD | Director/Board Member | 52 | 30/11/20 |
Roger Pomerantz
BRD | Director/Board Member | 67 | 22/05/22 |
Gili Hart
BRD | Director/Board Member | 49 | 31/12/13 |
Andrew Singer
BRD | Director/Board Member | 53 | 16/04/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,811,781 | 15,198,104 ( 80.79 %) | 0 | 80.79 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ENLV Stock
- 1BT Stock
- Company Enlivex Therapeutics Ltd.